Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects in type 1 diabetes underlining physiologic insulin signaling

被引：0
|
作者：
Horvath, K
Bock, G
Regittnig, W
Bodenlenz, M
Wutte, A
Theobald, K
Schweitzer, MA
Fuerstrecktenwald, S
Pieber, TR
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A332 / A332
页数：1
相关论文
共 50 条
  • [41] A direst comparison of insulin aspart and insulin lispro in patients with type 1 diabetes
    Plank, J
    Wutte, A
    Brunner, G
    Siebenhofer, A
    Semlitsch, B
    Sommer, R
    Hirschberger, S
    Pieber, TR
    [J]. DIABETES CARE, 2002, 25 (11) : 2053 - 2057
  • [42] Metabolic and immunologic effects of insulin lispro in gestational diabetes
    Jovanovic, L
    Ilic, S
    Pettitt, DJ
    Hugo, K
    Gutierrez, M
    Bowsher, RR
    Bastyr, EJ
    [J]. DIABETES CARE, 1999, 22 (09) : 1422 - 1427
  • [43] Time-action profile of insulin lispro and regular insulin in patients with type 1 diabetes and diabetic nephropathy
    Rave, R
    Sawicki, PT
    Heise, T
    Heinemann, L
    [J]. DIABETOLOGIA, 2000, 43 : A197 - A197
  • [44] Advantage of Insulin Glulisine Over Regular Insulin in Patients With Type 2 Diabetes and Severe Renal Insufficiency
    Urata, Hiromi
    Mori, Katsuhito
    Emoto, Masanori
    Yamazaki, Yuko
    Motoyama, Koka
    Morioka, Tomoaki
    Fukumoto, Shinya
    Koyama, Hidenori
    Shoji, Tetsuo
    Ishimura, Eiji
    Inaba, Masaaki
    [J]. JOURNAL OF RENAL NUTRITION, 2015, 25 (02) : 129 - 134
  • [45] Effects of a short-acting insulin analog (Insulin Lispro) versus regular insulin on lipid metabolism in insulin-dependent diabetes mellitus
    Caixàs, A
    Pérez, A
    Payés, A
    Otal, C
    Carreras, G
    Ordóñez-Llanos, J
    Reviriego, J
    Anderson, JH
    de Leiva, A
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (04): : 371 - 376
  • [46] Insulin aspart compared to regular insulin and insulin lispro in basal bolus therapy with NPH to treat pediatric patients with type 1 diabetes mellitus
    Arslanian, S
    Foster, C
    Wright, NM
    Stender, S
    Hales, P
    Hale, D
    [J]. DIABETOLOGIA, 2005, 48 : A327 - A327
  • [47] Comparison of insulin aspart, regular insulin, and insulin lispro in basal bolus therapy with NPH to treat pediatric patients with type 1 diabetes mellitus
    Arslanian, S
    Foster, C
    Wright, N
    Stender, S
    Hu, P
    Hale, P
    Hale, D
    [J]. DIABETES, 2005, 54 : A517 - A518
  • [48] A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy
    Gale, EAM
    [J]. DIABETIC MEDICINE, 2000, 17 (03) : 209 - 214
  • [49] Response to Jovanovic for the Comments on Our Study "Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial"
    van Bon, Arianne C.
    DeVries, J. Hans
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (08) : 871 - 871
  • [50] Efficacy and safety of insulin glulisine versus insulin lispro as part of a basal-bolus insulin regimen in children and adolescents with type I diabetes mellitus
    Philotheou, A.
    Arslanian, S.
    Blatniczky, L.
    Peterkova, V.
    Souhami, E.
    Danne, T.
    [J]. DIABETOLOGIA, 2008, 51 : S382 - S382
12345